Peptide internalization enabled by folding: Triple helical cell-penetrating peptides

Journal of Peptide Science

Volumn 21, Issue 2, 2015, Pages 77-84

  Shinde, Aparna ^a   Feher, Katie M ^a   Hu, Chloe ^a   Slowinska, Katarzyna ^a  

^a CALIFORNIA STATE UNIVERSITY   (United States)

Author keywords

Cell penetrating peptides; Collagen peptides; Enzymatic degradation; Internalization; Intracellular delivery; Triple helix

Indexed keywords

CELL PENETRATING PEPTIDE; GLYCINE; HYDROXYPROLINE; PROLINE;

AMINO ACID COMPOSITION; AMINO ACID SEQUENCE; ANIMAL CELL; ARGON LASER; ARTICLE; CELL MEMBRANE; CIRCULAR DICHROISM; COLORIMETRY; CONFOCAL MICROSCOPY; CYTOTOXICITY; ENZYMATIC DEGRADATION; FIBROBLAST; FLOW CYTOMETRY; HUMAN; HUMAN CELL; INTERNALIZATION; LEUKEMIA CELL; MOUSE; NONHUMAN; NUCLEOSOME; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN DOMAIN; PROTEIN FOLDING; PROTEIN SECONDARY STRUCTURE; PROTEIN STABILITY; THERMOSTABILITY; TRANSITION TEMPERATURE; TRIPLE HELIX; 3T3 CELL LINE; ANIMAL; CELL CULTURE; CELL MEMBRANE PERMEABILITY; CELL SURVIVAL; CHEMISTRY; DOSE RESPONSE; DRUG EFFECTS; JURKAT CELL LINE; STRUCTURE ACTIVITY RELATION;

ANIMALS; CELL MEMBRANE PERMEABILITY; CELL SURVIVAL; CELL-PENETRATING PEPTIDES; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; FIBROBLASTS; HUMANS; JURKAT CELLS; MICE; NIH 3T3 CELLS; PROTEIN FOLDING; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84921822526     PISSN: 10752617     EISSN: 10991387     Source Type: Journal    
DOI: 10.1002/psc.2725     Document Type: Article

References (35)

1. Wang B, Siahaan TJ, Soltero AR, (eds.). Drug Delivery: Principles and Applications, John Wiley & Sons Inc.: Hoboken, NJ, 2005.
2. Gu Z, Biswas A, ZhaoabM, Tang Y. Tailoring nanocarriers for intracellular protein delivery. Chem. Soc. Rev. 2011; 40: 3638-3655.
3. Khan DR. The use of nanocarriers for drug delivery in cancer therapy. J. Cancer Sci. & Therapy 2010; 2: 58-62.
4. Lindgren M, Hällbrink M, Prochiantz A, Langel U. Cell-penetrating peptides. Trends Pharmacol. Sci. 2000; 21: 99-103.
5. Wang F, Wanga Y, Zhanga X, Zhanga W, Guo S, Jin F. Recent progress of cell-penetrating peptides as new carriers for intracellular cargo delivery. J. Controlled Release. 2014; 174: 126-136.
6. Shin MC, Zhang J, Min KA, Lee K, Byun Y, David AE, He H, Yang VC. Cell-penetrating peptides: achievements and challenges in application for cancer treatment. J. Biomed. Mater. Res. Part A 2014; 102A: 575-587.
7. Gupta B, Levchenko TS, Torchilin VP. Intracellular delivery of large molecules and small particles by cell-penetrating proteins and peptides. Adv. Drug Deliv. Rev. 2005; 57: 637-651.
8. Reissmann S. Cell penetration: scope and limitations by the application of cell-penetrating peptides. J. Pept. Sci. 2014; 20: 760-784.
9. Palm-Apergi C, Lorents A, Padari K, Pooga M, Hallbrink M. The membrane repair response masks membrane disturbances caused by cell-penetrating peptide uptake. FASEB J. 2009; 23: 214-223.
10. Verdurmen WP, Brock R. Biological responses towards cationic peptides and drug carriers. Trends Pharmacol. Sci. 2011; 32: 116-124.
11. Cardozo AK, Buchillier V, Mathieu M, Chen J, Ortis F, Ladrière L, Allaman-Pillet N, Poirot O, Kellenberger S, Beckmann JS, Eizirik DL, Bonny C, Maurer F. Cell-permeable peptides induce dose- and lengthdependent cytotoxic effects. BBA Biomembranes 2007; 1768: 2222-2234.
12. Fillon YA, Anderson JP, Chmielewski J. Cell-penetrating agents based on a polyproline helix scaffolds. J. Am. Chem. Soc. 2005; 127: 11798-11799.
13. Pujals S, Giralt E. Proline-rich, amphipathic cell-penetrating peptides. Adv. Drug Delivery Rev. 2003; 55: 1679-1684.
14. Geisler I, Chmielewski J. Cationic amphiphilic polyproline helices: sidechain variations and cell-specific internalization. Chem. Biol. Drugs Des. 2009; 73: 39-45.
15. Mitchell DJ, Kim DT, Steinman W, Fathman CG, Rothbard JB. Polyarginine enters cells more efficiently than other polycationic homopolymers. J. Pept. Res. 2000; 56: 318-325.
16. Fonseca SB, Pereira MP, Kelley SO. Recent advances in the use of cellpenetrating peptides for medical and biological applications. Adv. Drug Deliv. Rev. 2009; 61: 953-964.
17. Futaki S, Nakase I, Tadokoro A, Takeuchi T, Jones A. Arginine-rich peptides and their internalization mechanisms. Biochem. Soc. Trans. 2007; 35: 784-787.
18. Schmidt N, Mishra A, Lai GH, Wong GC. Arginine-rich cell-penetrating peptides. FEBS Lett. 2010; 584: 1806-1813.
19. Futaki S. Arginine-rich peptides: potential for intracellular delivery of macromolecules and the mystery of the translocation mechanisms. Int. J. Pharm. 2002; 245: 1-7.
20. Nakase I, Takeuchi T, Tanaka G, Futaki S. Methodological and cellular aspects that govern the internalization mechanisms of arginine-rich cell-penetrating peptides. Adv. Drug Deliv. Rev. 2008; 60: 598-607.
21. Zhang XX, Eden HS, Chen X. Peptides in cancer nanomedicine: drug carriers, targeting ligands and protease substrates. J. Controlled Release 2012; 159: 2-13.
22. McGregor DP. Discovering and improving novel peptide therapeutics. Curr. Opin. Pharm. 2008; 8: 616-619.
23. Werle M, Bernkop-Schnurch A. Strategies to improve plasma half life time of peptide and protein drugs. Amino Acids 2006; 30: 351-367.
24. Yamazaki CM, Nakase I, Endo H, Kishimoto S, Mashiyama Y, Masuda R, Futaki S, Koide T. Collagen-like cell-penetrating peptides. Angew. Chem. Int. Ed. 2013; 52: 5497-5500.
25. Bella J, Eaton M, Brodsky B. Crystal structure andmolecular structure of a collagen-likepeptideat1.9angstromresolution. Science 1994;266:74-81.
26. Persikov AV, Ramshaw JAM, Brodsky B. Prediction of collagen stability from amino acid sequence. J. Biol. Chem. 2005; 280: 19343-19349.
27. VenugopalMG, Ramshaw JAM, Braswell E, Zhu D Brodsky B. Electrostatic interactions in collagen-like triple-helical peptides. Biochemistry 1994; 33: 7948-7956.
28. Yu SM, Li Y, Kim D. Collagen mimetic peptides: progress towards functional applications. Soft Matter 2011; 7: 7927-7938.
29. Powell MF, Stewart T, Otvos L, Jr, Urge L, Gaeta FCA, Sette A, Arrhenius T, Thomson D, Soda K, Colon SM. Peptide stability in drug development. 2. Effect of amino acid substitution and glycosylation on peptide reactivity in human serum. Pharm. Res. 1993; 10: 1268-1273.
30. Reimer AE, Feher K, Hernandez D, Slowinska K. Self-assembly of collagen peptides into hollow microtubules. J. Mater. Chem. 2012; 22: 7701-7703.
31. Ky D, Liu CK, Marumoto C, Castaneda L, Slowinska K. Electrochemical Time-of-Flight in crosslinked collagen matrix solution: implications of structural changes for drug delivery systems. J. Controlled Release 2006; 112: 214-222.
32. Fuchs SM, Raines RT. Polyarginine as a multifunctional fusion tag. Protein Sci. 2005; 14: 1538-1544.
33. Sakai N, Matile S. Anion-mediated transfer of polyarginine across liquid and bilayer membranes. J. Am. Chem. Soc. 2003; 125: 14348-14356.
34. El-Sayed A, Futaki S, Harashima H. Delivery of macromolecules using arginine-rich cell-penetrating peptides: ways to overcome endosomal entrapment. AAPS J. 2009; 11: 13-22.
35. Hwang E, Brodsky B. Folding delay and structural perturbations caused by type IV collagen natural interruptions and nearby Gly missense mutations. J. Biol. Chem. 2012; 287: 4368-4375.